Risk of myocardial infarction in patients with multiple sclerosis: a systematic review and meta-analysis

Multiple sclerosis (MS) is associated with increased cardiovascular morbidity, yet the magnitude of myocardial infarction (MI) risk remains uncertain. With newer cohort studies and advances in meta-analytic methods, an updated evidence synthesis is warranted. We conducted a systematic review and meta-analysis to quantify MI risk in MS patients. We searched PubMed, Embase, and Scopus from inception through December 2025 for observational studies comparing MI risk between adults with MS and controls. Random-effects meta-analysis using restricted maximum likelihood estimation with Hartung-Knapp-Sidik-Jonkman adjustment was performed. Risk of bias was assessed using the Newcastle-Ottawa Scale, and certainty of evidence was evaluated using GRADE. Mendelian randomization evidence was synthesized separately. Twenty cohorts from 18 studies were included. Seven cohorts (97,996 MS patients; 824,497 controls) contributed to the primary meta-analysis after excluding one study due to overlapping populations. MS patients had significantly increased MI risk (RR 1.70, 95% CI: 1.57–1.85; p < 0.0001) with moderate heterogeneity (I²=40.3%). The 95% prediction interval (1.60–1.81) indicated consistently elevated risk across settings. Secondary analyses showed increased stroke risk (RR 1.66, 95% CI: 1.01–2.73). Subgroup analyses revealed no significant differences by geographic region (p = 0.066), adjustment status (p = 0.45), or effect measure type (p = 0.79). Leave-one-out sensitivity analysis confirmed robust findings (RR range: 1.69–1.76). Mendelian randomization evidence showed a weak genetic association (OR 1.03, 95% CI: 1.00-1.06). GRADE certainty was very low. MS patients have a 70% increased risk of MI compared to individuals without MS. This risk elevation, comparable to other autoimmune conditions with established cardiovascular screening guidelines, supports the need for enhanced cardiovascular surveillance in MS populations.

Authors

Institutions

Publication Details

Journal
BMC Neurology
Published
2026-04-13
DOI
https://doi.org/10.1186/s12883-026-04882-w
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of myocardial infarction in patients with multiple sclerosis: a systematic review and meta-analysis

Sindhu Vasireddy, Shankar Kumar Biswas, Ayman Hamadttu, Yashasvi Srivastava
BMC Neurology
Multiple Sclerosis Research Studies
article

Risk of myocardial infarction in patients with multiple sclerosis: a systematic review and meta-analysis

Sindhu Vasireddy, Shankar Kumar Biswas, Ayman Hamadttu, Yashasvi Srivastava
article en

Abstract

Multiple sclerosis (MS) is associated with increased cardiovascular morbidity, yet the magnitude of myocardial infarction (MI) risk remains uncertain. With newer cohort studies and advances in meta-analytic methods, an updated evidence synthesis is warranted. We conducted a systematic review and meta-analysis to quantify MI risk in MS patients. We searched PubMed, Embase, and Scopus from inception through December 2025 for observational studies comparing MI risk between adults with MS and controls. Random-effects meta-analysis using restricted maximum likelihood estimation with Hartung-Knapp-Sidik-Jonkman adjustment was performed. Risk of bias was assessed using the Newcastle-Ottawa Scale, and certainty of evidence was evaluated using GRADE. Mendelian randomization evidence was synthesized separately. Twenty cohorts from 18 studies were included. Seven cohorts (97,996 MS patients; 824,497 controls) contributed to the primary meta-analysis after excluding one study due to overlapping populations. MS patients had significantly increased MI risk (RR 1.70, 95% CI: 1.57–1.85; p < 0.0001) with moderate heterogeneity (I²=40.3%). The 95% prediction interval (1.60–1.81) indicated consistently elevated risk across settings. Secondary analyses showed increased stroke risk (RR 1.66, 95% CI: 1.01–2.73). Subgroup analyses revealed no significant differences by geographic region (p = 0.066), adjustment status (p = 0.45), or effect measure type (p = 0.79). Leave-one-out sensitivity analysis confirmed robust findings (RR range: 1.69–1.76). Mendelian randomization evidence showed a weak genetic association (OR 1.03, 95% CI: 1.00-1.06). GRADE certainty was very low. MS patients have a 70% increased risk of MI compared to individuals without MS. This risk elevation, comparable to other autoimmune conditions with established cardiovascular screening guidelines, supports the need for enhanced cardiovascular surveillance in MS populations.

BMC Neurology
Ivano-Frankivsk National Medical University (UA), Abu Dhabi Falcon Hospital (AE), Sudan University of Science and Technology (SD)
Good health and well-being
Openalex Percentile: Top 18%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.